We are live on ! Find out more
SRRK icon

Scholar Rock

165 hedge funds and large institutions have $712M invested in Scholar Rock in 2024 Q2 according to their latest regulatory filings, with 32 funds opening new positions, 69 increasing their positions, 45 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

278% more call options, than puts

Call options by funds: $1.27M | Put options by funds: $337K

53% more repeat investments, than reductions

Existing positions increased: 69 | Existing positions reduced: 45

23% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 26

3% more funds holding

Funds holding: 160165 (+5)

1.73% less ownership

Funds ownership: 108.86%107.13% (-1.7%)

33% less funds holding in top 10

Funds holding in top 10: 32 (-1)

53% less capital invested

Capital invested by funds: $1.51B → $712M (-$794M)

Holders
165
Holders Change
+5
Holders Change %
+3.13%
% of All Funds
2.38%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
32
Increased
69
Reduced
45
Closed
26
Calls
$1.27M
Puts
$337K
Net Calls
+$937K
Net Calls Change
-$7.55M
Name Holding Trade Value Shares
Change
Change in
Stake
Marshall Wace
26
Marshall Wace
United Kingdom
$4.06M +$5.44M +444,961 +1,051%
Charles Schwab
27
Charles Schwab
California
$3.84M +$711K +58,173 +14%
CSS
28
Cubist Systematic Strategies
Connecticut
$3.66M +$3.23M +264,581 +151%
UBS Group
29
UBS Group
Switzerland
$3.54M -$87.4K -7,147 -2%
IHAM
30
Integral Health Asset Management
New York
$3.33M +$917K +75,000 +23%
Ameriprise
31
Ameriprise
Minnesota
$3.17M -$104K -8,470 -2%
DTC
32
Deep Track Capital
Connecticut
$3.1M -$3.76M -307,441 -45%
Axa
33
Axa
France
$3.1M +$2.53K +207 +0.1%
Balyasny Asset Management
34
Balyasny Asset Management
Illinois
$3.05M -$2.4M -196,141 -35%
TD Asset Management
35
TD Asset Management
Ontario, Canada
$2.58M
KCM
36
Kennedy Capital Management
Missouri
$2.33M +$49.6K +4,057 +1%
TI
37
Trexquant Investment
Connecticut
$2.27M +$1.65M +134,723 +98%
Citigroup
38
Citigroup
New York
$2.24M -$3.27M -267,048 -50%
D.E. Shaw & Co
39
D.E. Shaw & Co
New York
$2.12M +$1.74M +142,173 +127%
Bank of America
40
Bank of America
North Carolina
$2.11M +$181K +14,780 +6%
Dimensional Fund Advisors
41
Dimensional Fund Advisors
Texas
$2.07M -$495K -40,499 -14%
Morgan Stanley
42
Morgan Stanley
New York
$2.06M -$121K -9,888 -4%
Bank of New York Mellon
43
Bank of New York Mellon
New York
$1.92M +$409K +33,468 +17%
Qube Research & Technologies (QRT)
44
Qube Research & Technologies (QRT)
United Kingdom
$1.88M +$2.34M +191,788 +575%
Manulife (Manufacturers Life Insurance)
45
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$1.86M +$640K +52,329 +31%
LCM
46
Laurion Capital Management
New York
$1.79M -$3.79M -310,084 -59%
SSA
47
Schonfeld Strategic Advisors
New York
$1.73M +$837K +68,427 +49%
N
48
Nuveen
North Carolina
$1.63M -$1.07M -87,617 -31%
IC
49
Ikarian Capital
Texas
$1.53M -$1.32M -108,000 -37%
Wellington Management Group
50
Wellington Management Group
Massachusetts
$1.43M +$180K +14,695 +9%

SRRK Hedge Fund Activity: Q2 2024 in Review

165 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Scholar Rock (SRRK) for Q2 2024, worth a combined $712M — down 53% from $1.51B a quarter earlier.

Buyers outnumbered sellers: 32 funds opened new SRRK positions and 26 closed out — a net gain of 6 holders — while 69 added to existing stakes and 45 trimmed.

The largest buyer was Eventide Asset Management, adding an estimated $19.1M. The largest seller was OrbiMed, cutting an estimated $30.6M.

  • 165 institutional investors held Scholar Rock (SRRK) as of Q2 2024, up from 160 in Q1 2024.
  • Funds reported $712M of Scholar Rock stock for Q2 2024, down 53% quarter-over-quarter.
  • 32 funds opened new Scholar Rock positions in Q2 2024 and 26 closed out, a net change of +6 holders.
  • The largest Scholar Rock buyer in Q2 2024 was Eventide Asset Management, an estimated $19.1M added.
  • The largest Scholar Rock seller in Q2 2024 was OrbiMed, an estimated $30.6M sold.

Based on aggregated 13F filings for Q2 2024.